Billionaires Holding SNSS

BILLIONAIRE ALLOCATION SHARES OWNED (M) % CO AVG. COST RETURN

FUNDAMENTALS

  • N/A
    PE

  • 0.0
    Yield

  • 61.9M
    Shares Outstanding

  • 45.21M
    Market Cap

News & Insights

ABOUT

SNSS

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. The company’s lead product candidate is vosaroxin, an anti-cancer quinolone derivative for the treatment of acu...

Here’s Buffett’s Most Recent Acquisition

NEWS

Herbalife: Carl Icahn Comes Out On Top

READ MORE